UGC Chairman Professor Dr Mamun Ahmed said biotechnology curricula are still overly theoretical and not aligned with industry needs.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced it has received the ...

John Crowley, Biotechnology Innovation Organization (BIO) president and CEO, joins 'Squawk Box' to discuss 50 years of ...

LifeSciencesNY, a trade group based in Central New York, urges state legislators to fund this effort in the upcoming state ...

Reimbursement systems in Belgium and Europe are not prepared for cell and gene therapies Bayer’s Benelux head, Niels Hessmann ...

Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the ...

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

On 16 December 2025, the European Commission proposed a package of measures to improve the health of EU citizens, while ensuring the long-term resilience and competitiveness of the EU health sector.

ORLANDO, FL / ACCESS Newswire / April 20, 2026 / RedChip Companies, an industry leader in investor relations, media, ...

The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...

Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...

Fred Ramsdell traces his journey from a Bill Gates-backed startup in the mid '90s to the Nobel stage in 2025 for his work in ...